NewsAddressing the Burden of Hidradenitis Suppurativa: The Often-Hidden Impact on Quality of LifeRead more →Read more →
NewsPatient-Centric Data Capture Fuels Growth of Target RWE Longitudinal, Real-World Dermatology StudiesRead more →Read more →
NewsPatient-Reported Outcomes Data from Longest Running Dermatology Study: TARGET-DERM AA Poster Presented at American Academy of Dermatology (AAD) 2024Read more →Read more →
Addressing the Burden of Hidradenitis Suppurativa: The Often-Hidden Impact on Quality of LifeRead more →
Patient-Centric Data Capture Fuels Growth of Target RWE Longitudinal, Real-World Dermatology StudiesRead more →
Patient-Reported Outcomes Data from Longest Running Dermatology Study: TARGET-DERM AA Poster Presented at American Academy of Dermatology (AAD) 2024Read more →
Longest Running Real World Dermatology Registry, TARGET-DERM, Offers Deep Insight into Complex DiseasesRead more →
TARGET PharmaSolutions to Advance Dermatology Research, including Atopic Dermatitis, through New CollaborationRead more →
TARGET PharmaSolutions Launches TARGET-DERM Real-World Observational Study to Advance the Understanding of Atopic Dermatitis (Eczema) and Other Immune-Mediated Inflammatory Skin ConditionsRead more →
